Oncternal Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Oncternal Therapeutics by BlackRock
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $299k | 39k | 7.60 |
2024-03-31 | $354k | 39k | 9.00 |